Stephanie Cossette currently serves as Study Director for Toxicology at Labcorp Drug Development, leading Safety Assessment studies focusing on Cell and Gene Therapy and oncology, among other areas. Previously, Stephanie held the role of President and CEO at Angio360 Diagnostics LLC, where innovative cancer diagnostic tools were developed for both veterinary and human use while managing business operations and securing funding. With extensive experience as a Postdoctoral Research Fellow at the Children's Hospital of Wisconsin and in various consulting roles, Stephanie has contributed significantly to multiple research projects and has a strong background in molecular biology, biochemistry, and project management. Stephanie holds a PhD in Biochemistry from the Medical College of Wisconsin and possesses various degrees from the University of Western Ontario, including an MSc in Physiology and a Bachelor's in Genetics.
This person is not in any teams
This person is not in any offices